用于前列腺癌初步诊断的新型非MRI成像技术:微超声、超声造影、弹性成像、多参数超声和PSMA PET/CT
本文为一项批判性文献综述,检索PubMed®、Web of Science™和Scopus®三个数据库,纳入回顾性与前瞻性研究、系统综述及Meta分析,定性描述超声与核医学成像在前列腺癌初诊中的诊断表现。微超声诊断准确性高,似乎不劣于mpMRI;多参数超声联合多种模态可能带来效果优势;PSMA PET/CT可能代表全身一步式诊断与分期方法。各技术均存在固有局限,需进一步研究方能可靠用于前列腺癌准确诊断。
要点
- 微超声诊断前列腺癌准确性高,似乎不劣于mpMRI。
- 多参数超声联合不同模态可能带来效果优势,但研究数量有限,证据仍为初步。
- PSMA PET/CT可能代表全身一步式诊断与分期方法,但各技术均有固有局限,需进一步研究。
核心结论
- 非MRI成像选项在前列腺癌初步诊断中的证据正在稳步积累,反映对可能克服当前金标准MRI成像部分局限的新技术的兴趣日益增长。
研究设计与样本
- 批判性文献综述,检索PubMed®、Web of Science™和Scopus®三个数据库,纳入回顾性与前瞻性研究(比较与非比较)、系统综述和Meta分析,由作者根据专家意见选择研究、提取数据并定性描述结果。
主要发现
- 微超声因检测前列腺癌准确性高而似乎是有吸引力的诊断策略,似乎不劣于mpMRI。
- 多参数超声可能因不同模态组合而带来效果优势,尤其在某些模态联合时。
- PSMA PET/CT可能代表全身一步式方法,用于前列腺癌的适当诊断与分期。
- 放射性示踪剂病灶摄取与组织病理学和预后特征之间的直接关系及其有效诊断表现是有吸引力的特征。
- 弹性成像和多参数超声等其他新技术目前依赖有限数量的研究,因此相关证据仍为初步。
局限性
- 每种技术均存在固有局限。
- 在最终将其视为准确诊断前列腺癌的可靠工具之前,需进一步研究。
- 弹性成像和多参数超声等其他新技术目前依赖有限数量的研究,相关证据仍为初步。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiparametric magnetic resonance imaging (mpMRI) provides enhanced diagnostic accuracy in the detection of prostate cancer, but is not devoid of limitations. Given the recent evolution of non-MRI imaging techniques, this critical review of the literature aimed at summarizing the available evidence on ultrasound-based and nuclear medicine imaging technologies in the initial diagnosis of PCa. METHODS: Three databases (PubMed®, Web of Science™, and Scopus®) were queried for studies examining their diagnostic performance in the primary diagnosis of PCa, weighted against a histological confirmation of PCa diagnosis, using a free-text protocol. Retrospective and prospective studies, both comparative and non-comparative, systematic reviews (SR) and meta-analysis (MA) were included. Based on authors' expert opinion, studies were selected, data extracted, and results qualitatively described. RESULTS: Micro-ultrasound (micro-US) appears as an appealing diagnostic strategy given its high accuracy in detection of PCa, apparently non-inferior to mpMRI. The use of multiparametric US (mpUS) likely gives an advantage in terms of effectiveness coming from the combination of different modalities, especially when certain modalities are combined. Prostate-specific membrane antigen (PSMA) PET/CT may represent a whole-body, one-step approach for appropriate diagnosis and staging of PCa. The direct relationship between lesions avidity of radiotracers and histopathologic and prognostic features, and its valid diagnostic performance represents appealing characteristics. However, intrinsic limits of each of these techniques exist and further research is needed before definitively considering them reliable tools for accurate PCa diagnosis. Other novel technologies, such as elastography and multiparametric US, currently relies on a limited number of studies, and therefore evidence about them remains preliminary. CONCLUSION: Evidence on the role of non-MRI imaging options in the primary diagnosis of PCa is steadily building up. This testifies a growing interest towards novel technologies that might allow overcoming some of the limitations of current gold standard MRI imaging.
引用
- Ditonno F, Franco A, Manfredi C, et al. Novel non-MRI imaging techniques for primary diagnosis of prostate cancer: micro-ultrasound, contrast-enhanced ultrasound, elastography, multiparametric ultrasound, and PSMA PET/CT. Prostate Cancer Prostatic Dis. 2023. PMID: 37543656. doi:10.1038/s41391-023-00708-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。